Logo image of SCNI

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Price, Quote, News and Overview

NASDAQ:SCNI - Nasdaq - US09073Q3039 - ADR - Currency: USD

2.5135  +0.09 (+3.86%)

SCNI Quote, Performance and Key Statistics

SCINAI IMMUNOTHERAPEUTICS LT

NASDAQ:SCNI (4/25/2025, 8:00:01 PM)

2.5135

+0.09 (+3.86%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High8.92
52 Week Low1.9
Market Cap2.35M
Shares933.70K
Float724.99K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-07 2007-06-07


SCNI short term performance overview.The bars show the price performance of SCNI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20

SCNI long term performance overview.The bars show the price performance of SCNI in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of SCNI is 2.5135 USD. In the past month the price decreased by -13.33%. In the past year, price decreased by -45.1%.

SCINAI IMMUNOTHERAPEUTICS LT / SCNI Daily stock chart

SCNI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.12 329.14B
AMGN AMGEN INC 14.17 150.99B
GILD GILEAD SCIENCES INC 13.33 128.61B
VRTX VERTEX PHARMACEUTICALS INC 1702.9 126.96B
REGN REGENERON PHARMACEUTICALS 13.2 65.88B
ARGX ARGENX SE - ADR 323.56 37.54B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.72B
ONC BEIGENE LTD-ADR N/A 26.39B
BNTX BIONTECH SE-ADR N/A 24.52B
NTRA NATERA INC N/A 20.79B
BIIB BIOGEN INC 7.22 17.39B
SMMT SUMMIT THERAPEUTICS INC N/A 17.30B

About SCNI

Company Profile

SCNI logo image Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Company Info

SCINAI IMMUNOTHERAPEUTICS LT

Jerusalem Biopark, 2Nd Floor, Hadassah Ein Kerem Campus

JERUSALEM IL

Employees: 31

Company Website: https://www.scinai.com/

Investor Relations: http://www.biondvax.com/investors/

Phone: 97289302529

SCINAI IMMUNOTHERAPEUTICS LT / SCNI FAQ

What is the stock price of SCINAI IMMUNOTHERAPEUTICS LT today?

The current stock price of SCNI is 2.5135 USD. The price increased by 3.86% in the last trading session.


What is the ticker symbol for SCINAI IMMUNOTHERAPEUTICS LT stock?

The exchange symbol of SCINAI IMMUNOTHERAPEUTICS LT is SCNI and it is listed on the Nasdaq exchange.


On which exchange is SCNI stock listed?

SCNI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SCINAI IMMUNOTHERAPEUTICS LT stock?

7 analysts have analysed SCNI and the average price target is 714 USD. This implies a price increase of 28306.6% is expected in the next year compared to the current price of 2.5135. Check the SCINAI IMMUNOTHERAPEUTICS LT stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SCINAI IMMUNOTHERAPEUTICS LT worth?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a market capitalization of 2.35M USD. This makes SCNI a Nano Cap stock.


How many employees does SCINAI IMMUNOTHERAPEUTICS LT have?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) currently has 31 employees.


What are the support and resistance levels for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a resistance level at 3.16. Check the full technical report for a detailed analysis of SCNI support and resistance levels.


Should I buy SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock pay dividends?

SCNI does not pay a dividend.


What is the Price/Earnings (PE) ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI)?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.7).


What is the Short Interest ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

The outstanding short interest for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 0.26% of its float. Check the ownership tab for more information on the SCNI short interest.


SCNI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SCNI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SCNI. SCNI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SCNI Financial Highlights

Over the last trailing twelve months SCNI reported a non-GAAP Earnings per Share(EPS) of -18.7. The EPS increased by 109% compared to the year before.


Industry RankSector Rank
PM (TTM) 561.28%
ROA 20.69%
ROE 25.36%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)109%
Revenue 1Y (TTM)N/A

SCNI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to SCNI. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners13.75%
Ins Owners7.62%
Short Float %0.26%
Short Ratio0.15
Analysts
Analysts82.86
Price Target714 (28306.6%)
EPS Next Y98.91%
Revenue Next YearN/A